Eli Lilly’s diabetes treatment Mounjaro, which is widely used for weight-loss, raked in nearly $1 billion in second-quarter sales, or more than $200 million above what Wall Street had expected. Lydia Moynihan discusses why companies that sell these diabetes drugs that can also be used as weight-loss drugs are so profitable. Watch #MorningInAmerica: newsnationnow.com/joinus #weightloss #EliLilly #sales Start your day with "Morning in America," NewsNation's live three-hour national morning newscast hosted by Adrienne Bankert. Weekdays starting at 7a/6C. #MorningInAmerica NewsNation is your source for fact-based, unbiased news for all America. More from NewsNation: newsnationnow.com Get our app: trib.al/TBXgYpp Find us on cable: trib.al/YDOpGyG How to watch on TV or streaming: trib.al/Vu0Ikij